These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 27344221)
1. A Classification Tool for Differentiation of Kawasaki Disease from Other Febrile Illnesses. Hao S; Jin B; Tan Z; Li Z; Ji J; Hu G; Wang Y; Deng X; Kanegaye JT; Tremoulet AH; Burns JC; Cohen HJ; Ling XB; J Pediatr; 2016 Sep; 176():114-120.e8. PubMed ID: 27344221 [TBL] [Abstract][Full Text] [Related]
2. Multicentre validation of a computer-based tool for differentiation of acute Kawasaki disease from clinically similar febrile illnesses. Hao S; Ling XB; Kanegaye JT; Bainto E; Dominguez SR; Heizer H; Jone PN; Anderson MS; Jaggi P; Baker A; Son MB; Newburger JW; Ashouri N; McElhinney DB; Burns JC; Whitin JC; Cohen HJ; Tremoulet AH; Arch Dis Child; 2020 Aug; 105(8):772-777. PubMed ID: 32139365 [TBL] [Abstract][Full Text] [Related]
3. Urinary Colorimetric Sensor Array and Algorithm to Distinguish Kawasaki Disease from Other Febrile Illnesses. Li Z; Tan Z; Hao S; Jin B; Deng X; Hu G; Liu X; Zhang J; Jin H; Huang M; Kanegaye JT; Tremoulet AH; Burns JC; Wu J; Cohen HJ; Ling XB; PLoS One; 2016; 11(2):e0146733. PubMed ID: 26859297 [TBL] [Abstract][Full Text] [Related]
4. Point-of-care differentiation of Kawasaki disease from other febrile illnesses. Ling XB; Kanegaye JT; Ji J; Peng S; Sato Y; Tremoulet A; Burns JC; Cohen HJ J Pediatr; 2013 Jan; 162(1):183-188.e3. PubMed ID: 22819274 [TBL] [Abstract][Full Text] [Related]
5. Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children. Connelly MA; Shimizu C; Winegar DA; Shalaurova I; Pourfarzib R; Otvos JD; Kanegaye JT; Tremoulet AH; Burns JC BMC Pediatr; 2016 Sep; 16(1):151. PubMed ID: 27596163 [TBL] [Abstract][Full Text] [Related]
7. A diagnostic algorithm combining clinical and molecular data distinguishes Kawasaki disease from other febrile illnesses. Ling XB; Lau K; Kanegaye JT; Pan Z; Peng S; Ji J; Liu G; Sato Y; Yu TT; Whitin JC; Schilling J; Burns JC; Cohen HJ BMC Med; 2011 Dec; 9():130. PubMed ID: 22145762 [TBL] [Abstract][Full Text] [Related]
8. Single center blind testing of a US multi-center validated diagnostic algorithm for Kawasaki disease in Taiwan. Kuo HC; Hao S; Jin B; Chou CJ; Han Z; Chang LS; Huang YH; Hwa K; Whitin JC; Sylvester KG; Reddy CD; Chubb H; Ceresnak SR; Kanegaye JT; Tremoulet AH; Burns JC; McElhinney D; Cohen HJ; Ling XB Front Immunol; 2022; 13():1031387. PubMed ID: 36263040 [TBL] [Abstract][Full Text] [Related]
9. Prediction Model for the Differential Diagnosis of Kawasaki Disease and Acute Cervical Lymphadenitis in Patients Initially Presenting with Fever and Cervical Lymphadenitis. Kim JM; Kim J J Pediatr; 2020 Oct; 225():30-36.e2. PubMed ID: 32450069 [TBL] [Abstract][Full Text] [Related]
10. Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease. Reddy M; Singh S; Rawat A; Sharma A; Suri D; Rohit MK Rheumatol Int; 2016 Apr; 36(4):551-9. PubMed ID: 26849890 [TBL] [Abstract][Full Text] [Related]
11. Examining the Utility of Coronary Artery Lack of Tapering and Perivascular Brightness in Incomplete Kawasaki Disease. Rabinowitz EJ; Rubin LG; Desai K; Hayes DA; Tugertimur A; Kwon EN; Dhanantwari P; Misra N; Stoffels G; Blaufox AD; Mitchell E Pediatr Cardiol; 2019 Jan; 40(1):147-153. PubMed ID: 30196380 [TBL] [Abstract][Full Text] [Related]
12. Acute febrile cholestatic jaundice in children: keep in mind Kawasaki disease. Taddio A; Pellegrin MC; Centenari C; Filippeschi IP; Ventura A; Maggiore G J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):380-3. PubMed ID: 22437475 [TBL] [Abstract][Full Text] [Related]
15. Clinical manifestations of Kawasaki disease: what are the significant parameters? Chaiyarak K; Durongpisitkul K; Atta T; Soongswang J; Laohaprasitiporn D; Nana A Asian Pac J Allergy Immunol; 2009; 27(2-3):131-6. PubMed ID: 19839499 [TBL] [Abstract][Full Text] [Related]
16. Risk of coronary artery lesions in young infants with Kawasaki disease: need for a new diagnostic method. Satoh K; Wakejima Y; Gau M; Kiguchi T; Matsuda N; Takasawa R; Takasawa K; Nishioka M; Shimohira M Int J Rheum Dis; 2018 Mar; 21(3):746-754. PubMed ID: 29105337 [TBL] [Abstract][Full Text] [Related]
17. N-terminal pro-B-type natriuretic peptide diagnostic algorithm versus American Heart Association algorithm for Kawasaki disease. Dionne A; Meloche-Dumas L; Desjardins L; Turgeon J; Saint-Cyr C; Autmizguine J; Spigelblatt L; Fournier A; Dahdah N Pediatr Int; 2017 Mar; 59(3):265-270. PubMed ID: 27589358 [TBL] [Abstract][Full Text] [Related]
18. Observational study of Interleukin-21 (IL-21) does not distinguish Kawasaki disease from other causes of fever in children. Engelberg R; Martin M; Wrotniak BH; Hicar MD Pediatr Rheumatol Online J; 2017 Apr; 15(1):32. PubMed ID: 28427414 [TBL] [Abstract][Full Text] [Related]
19. Novel Risk Assessment Tool for Immunoglobulin Resistance in Kawasaki Disease: Application Using a Random Forest Classifier. Takeuchi M; Inuzuka R; Hayashi T; Shindo T; Hirata Y; Shimizu N; Inatomi J; Yokoyama Y; Namai Y; Oda Y; Takamizawa M; Kagawa J; Harita Y; Oka A Pediatr Infect Dis J; 2017 Sep; 36(9):821-826. PubMed ID: 28441265 [TBL] [Abstract][Full Text] [Related]